Viatris to Buy Pacira; Stock Pops 44% After the Bell
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
- Seeking AlphaPacira BioSciences jumps 44% on Viatris acquisition deal
“Thank you, Dale. For the record, the S and P 500 is down point four seven percent. Viatris gets the pain company.”



